title: Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.
authors.affiliation: Istituto di Ematologia Universita' Cattolica del Sacro Cuore, Policlinico A Gemelli, Rome, Italy.
authors.forename: Laura
authors.initials: L
authors.lastname: De Padua
authors.forename: Luca
authors.initials: L
authors.lastname: Laurenti
authors.forename: Paolo
authors.initials: P
authors.lastname: Falcucci
authors.forename: Giovanni
authors.initials: G
authors.lastname: D'arena
authors.forename: Barbara
authors.initials: B
authors.lastname: Vannata
authors.forename: Idanna
authors.initials: I
authors.lastname: Innocenti
authors.forename: Francesco
authors.initials: F
authors.lastname: Autore
authors.forename: Nicola
authors.initials: N
authors.lastname: Piccirillo
authors.forename: Tommaso
authors.initials: T
authors.lastname: Za
authors.forename: Sara
authors.initials: S
authors.lastname: Marietti
authors.forename: Dimitar G
authors.initials: DG
authors.lastname: Efremov
authors.forename: Simona
authors.initials: S
authors.lastname: Sica
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis* / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D003520:Cyclophosphamide; D014740:Vidarabine; C024352:fludarabine